コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 related with epicatechin and epicatechin-3-O-gallate.
2 hin and epicatechin, but not epicatechin-3-O-gallate.
3 industry, BHT, alpha-tocopherol, and dodecyl gallate.
4 constant, followed by (-)-epigallocatechin-3-gallate.
5 redox-active cofactors such as ascorbate and gallate.
6 ls, epigallocatechin gallate and epicatechin gallate.
7 the antioxidants ascorbic acid and n-propyl gallate.
8 some EGCG epimerized to (+)-gallocatechin-3-gallate.
9 y the anti-amyloid compound epigallocatechin-gallate.
10 he abundance of EGC, theanine and afzelechin gallate.
11 eviously to be better surfactants than alkyl gallates.
12 In addition, about 130 genes in the large gallate 1-beta-glucosyltransferase (GGT) superfamily wer
14 tion) than amylose (IC(50): epigallocatechin gallate = 20.41 +/- 0.25 uM, quercetagetin = 30.15 +/- 2
15 he green tea extract, (-)-epigallocatechin-3-gallate [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl
16 tea-derived flavanol, (-)-epigallocatechin 3-gallate [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl
18 nalysis using luteolin (12) and (-)-catechin gallate (37) as model compounds revealed that FabG was i
19 abundant being gallic acid, (-)-epicatechin-gallate, 4-p-coumaroylquinic acid, quercetin-3-O-galacto
20 uced higher decrease in (-)-epigallocatechin gallate (71% and 79%) and quercetin-3-glucoside (29% and
21 (1475-2,070 mug/g extracts) and epicatechin gallate (885-1,603 mug/g extracts); while all-trans-lute
22 6)-membrane interactions by epigallocatechin gallate, a known modulator of amyloid peptide aggregatio
24 n tea extracts containing epigallocatechin 3-gallate, a potent DYRK1A inhibitor, to adult mBACtgDyrk1
26 recently showed that (-)-epigallocatechin-3-gallate, a tea polyphenol, not only inhibits L-DOPA meth
27 y analysis also showed that epigallocatechin gallate ameliorated vesicle disruption by PrP(106-126).
29 -)-epicatechin gallate, (-)-epigallocatechin gallate and (-)-epigallocatechin protected at lowest con
30 high binding energies for (-)-epicatechin-3-gallate and (-)-epigallocatechin-3-gallate for the bindi
31 ddition of the antioxidants epigallocatechin gallate and alpha-lipoic acid reduces polyglutamine aggr
34 verages were incubated with epigallocatechin gallate and green tea extract at 62 or 37 degrees C for
36 a oligomers is inhibited by epigallocatechin gallate and increased by the A2V mutation, previously re
39 ain inhibition mechanism of epigallocatechin gallate and punicalagin was through complexation with st
40 pplementation of combined epigallocatechin-3-gallate and resveratrol (EGCG+RES) increased energy expe
41 by two amyloid inhibitors (epigallocatechin gallate and scyllo-inositol) that are currently in clini
42 he green tea polyphenol (-)-epigallocatechin gallate and the red wine extract resveratrol both remode
43 , (+)-catechin, gallocatechin, gallocatechin gallate and theasinensin B, and lower levels of (-)-epic
44 , (+)-catechin, gallocatechin, gallocatechin gallate and theasinensin B, and lower levels of (-)-epic
46 n acyl-hydrolase hydrolyzing HTs, CT monomer gallates and depsides - has been reported in microbes on
47 nti-peroxide activity of gallic acid, methyl gallate, and alpha-tocopherol in a bulk Kilka fish oil a
48 ( approximately 100%), for Trolox, n-propyl gallate, and ascorbic acid the extent of geminate recomb
49 han, isonicotinylhydrazide, epigallocatechin gallate, and curcumin as reducing and stabilizing agents
50 ecially epigallocatechin galate, epicatechin gallate, and epicatechin) than tea infused at 80 degrees
51 n hazelnut shells were catechin, epicatechin gallate, and gallic acid, as quantified by high performa
52 atrol, Curcumin, Quercetin, Epigallocatechin Gallate, and Genistein) for further examination of their
53 including (+)-catechin, (-)-epigallocatechin gallate, and green tea extract were added to washed MFGs
54 (TFdiG), theaflavin-3'-gallate, theaflavin-3-gallate, and theaflavin inhibited PL with IC50 of 1.9, 4
55 ration containing 65% (-)-epigallocatechin-3-gallate] and caffeine on 4-(methylnitrosamino)-1-(3-pyri
57 tannins [procyanidin B2, procyanidin B2 3'-O-gallate (B2g) and procyanidin trimer (catechin-4-8-catec
58 ent- and bitter-tasting (-)-epigallocatechin gallate, bitter-tasting caffeine, and the umami-tasting
59 ts reveal that polyphenols (epigallocatechin gallate, bromophenol blue, and resveratrol) and glycosam
60 ctivity of gallic acid and a series of alkyl gallates (C4-C18) and glycosylated alkyl gallates (C4-C1
61 kyl gallates (C4-C18) and glycosylated alkyl gallates (C4-C18) on fish oil-in-water emulsions was stu
64 compounds, such as gallic acid, epicatechin gallate, catechin, epicatechin and isoquercitrin, were i
66 tor of glucose uptake into Caco-2 cells, and gallated catechins the most potent: CG > ECG > EGCG >= G
68 more active (IC50 = 31 microM) than catechin gallate (CG, IC50 = 53 microM) or epicatechin gallate (E
69 of hydrolysable polyphenols (gallic acid 3-O-gallate, cinnamic acid, hesperidin, myricetin 3-O-rhamno
70 uclear perfluoroarylborate, -aluminate, and -gallate cocatalysts/activators B(C6F5)3 (3), B(o-C6F5C6F
71 n and tau aggregation, that epigallocatechin gallate decreases aSyn aggregation, and that dynasore re
73 othiocyanates; G) and (-)-epigallocatechin-3-gallate (E) were investigated in colon (LoVo and CaCo-2)
74 (EC), epigallocatechin (EGC), epicatechin 3-gallate (ECG) and epigallocatechin 3-gallate (EGCG) and
75 etics (in the order of minutes), epicatechin gallate (ECG) and epigallocatechin gallate (ECGC) exhibi
77 ocatechin-3-gallate (GCG), and epicatechin-3-gallate (ECG)) and not the catechol-type catechins (cate
78 gallocatechin gallate (EGCG) and epicatechin gallate (ECG)) inhibit GDH in vitro and that EGCG blocks
80 allate (CG, IC50 = 53 microM) or epicatechin gallate (ECG, IC50 = 76 microM) against the colorectal a
81 n C, (-)-epicatechin EC, (-)-epicatechin-3-O-gallate, ECG] and oligomers [B1, B2, B3, B4 dimers and t
82 icatechin gallate (ECG) and epigallocatechin gallate (ECGC) exhibited very rapid binding (in the orde
83 epicatechin or its analogue epigallocatechin gallate (EGCG) (0.25% w/v in drinking water) was adminis
84 mg/daclatisvir (DCV) 60 mg/epigallocatechin gallate (EGCG) 400 mg without ribavirin (RBV); and Dacta
88 , ACS1, and the antioxidant epigallocatechin gallate (EGCG) all stimulated GSH levels and significant
89 llocatechin (EGC) and (-)-epigallocatechin-3-gallate (EGCG) and butylated hydroxytoluene (BHT) correl
90 more, stems contained lower epigallocatechin gallate (EGCG) and caffeine (ca. 75 and 56%, respectivel
91 echin 3-gallate (ECG) and epigallocatechin 3-gallate (EGCG) and caffeine in 29 commercial green tea s
92 ituents of green tea, (-)-epigallocatechin-3-gallate (EGCG) and caffeine, on intestinal tumorigenesis
94 polyphenols from green tea (epigallocatechin gallate (EGCG) and epicatechin gallate (ECG)) inhibit GD
95 the four compounds tested, epigallocatechin gallate (EGCG) and epicatechin gallate were found to inh
96 tituents, in particular (-)-epigallocatechin gallate (EGCG) and other polyphenols with 1,2-benzenedio
98 the polyphenolic compounds epigallocatechin gallate (EGCG) and silibinin bind to specific conformers
99 tea catechins such as (-)epigallocatechin-3-gallate (EGCG) are known to improve energy metabolism at
100 -unexplored property of (-)-epigallocatechin gallate (EGCG) as a chiral solvating agent for enantiodi
101 Here, we identify (-)-epigallocatechin-3-gallate (EGCG) as a new inhibitor of hepatitis C virus (
103 est green tea-derived (-)-epigallocatechin-3-gallate (EGCG) can attenuate neuronal damage mediated by
104 an ingredient of green tea, epigallocatechin gallate (EGCG) could attenuate oxidative stress-induced
105 Green tea polyphenol, epigallocatechin-3-gallate (EGCG) differentially regulates the cellular gro
108 green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) exerts a beneficial role on reducing brai
109 It was reported that epigallocatechin-3-gallate (EGCG) exhibits anti-inflammatory properties, bu
110 hat prostate tumor specific epigallocatechin-gallate (EGCg) functionalized radioactive gold nanoparti
111 ea-derived polyphenol (-)-epigallocatechin-3-gallate (EGCG) has been extensively studied for its anti
113 etinamide (4-HPR) and (-)-epigallocatechin-3-gallate (EGCG) in altering expression of oncogenic micro
115 evaluate the efficacy of epigallocatechin-3-gallate (EGCG) in down-regulating Mcl-1 expression and i
116 tive botanicals including epigallocatechin-3-gallate (EGCG) in green tea polyphenols (GTPs) and sulfo
117 ated green tea polyphenol epigallocatechin-3-gallate (EGCG) in polylactic acid-polyethylene glycol na
118 n of green tea catechin and epigallocatechin gallate (EGCG) in soy lecithin liposomes was examined at
119 techins epicatechin (EC) or epigallocatechin gallate (EGCG) inhibited formation of highly reactive in
120 the green tea polyphenol epigallocatechin-3 gallate (EGCG) inhibits growth and transformed phenotype
121 tive green tea polyphenol epigallocatechin-3-gallate (EGCG) inhibits growth in soft agar of breast ca
122 the green tea polyphenol epigallocatechin 3-gallate (EGCG) inhibits growth of NF639 Her-2/neu-driven
126 that the commonly used (-)-epigallocatechin gallate (EGCG) is a much less efficient amyloid inhibito
129 ated that the GT polyphenol epigallocatechin gallate (EGCG) is capable of antagonizing AhR-mediated g
130 gents like the polyphenol epigallocatechin-3-gallate (EGCG) is emerging as an experimental secondary
131 The green tea catechin epigallocatechin-3-gallate (EGCG) is generally considered to be the biologi
137 The green tea component epigallocatechin-3-gallate (EGCG) may be beneficial in autoimmune diseases;
138 TE) supplementation high in epigallocatechin gallate (EGCG) on blood lipids in healthy postmenopausal
139 effect of the polyphenol epigallocatechin 3-gallate (EGCG) on hCT fibrillation was also investigated
140 the green tea polyphenol epigallocatechin-3 gallate (EGCG) on mammary tumor cells were assessed.
141 esveratrol, curcumin, and epigallocatechin-3-gallate (EGCG) on the aggregation of Abeta(17-36) peptid
143 400muM) and influence (-)-epigallocatechin-3-gallate (EGCG) oxidation (400muM) in Tween- or sodium do
146 th a standardized dose of epigallocatechin-3-gallate (EGCG) was administered using the standard phase
150 mponent in green tea, (-)-epigallocatechin-3-gallate (EGCG)'s potential benefits to human health have
151 vestigated the effects of epigallocatechin-3-gallate (EGCG), a bioactive green tea polyphenol, on EGF
154 ine whether the antioxidant epigallocatechin gallate (EGCG), a catechin-base flavonoid derived from g
155 was to provide support for epigallocatechin gallate (EGCG), a component of green tea, to be consider
156 nd in vivo treatment with Epigallocatechin-3-gallate (EGCG), a Dyrk1a inhibitor, modulated trisomic N
157 uded three phenolics: (-)-epigallocatechin-3-gallate (EGCG), a flavanoid polyphenol found in green te
158 orted previously that (-)-epigallocatechin-3-gallate (EGCG), a green tea polyphenol antioxidant, stim
159 entified in this study that epigallocatechin gallate (EGCG), a green tea-derived catechin, acts as a
163 t studies have shown that epigallocatechin-3-gallate (EGCG), a major constituent of green tea extract
169 are mainly attributed to epigallocatechin-3-gallate (EGCG), a polyphenolic compound from the group o
171 oneally injected with (-)-epigallocatechin-3-gallate (EGCG), a redox-active polyphenol from green tea
172 ermine to what extent (-)-epigallocatechin-3-gallate (EGCG), a widely used dietary supplement, modula
174 s, and the polyphenol (-)-epigallocatechin-3-gallate (EGCG), and has been implicated in a number of d
175 f a model polyphenol, (-)-epigallocatechin-3-gallate (EGCG), and matrix pH (2-7) on the net anti-/pro
176 cysteine (NAC), curcumin, epigallocatechin-3 gallate (EGCG), and p38 inhibitor SB203580 were added to
177 ajor green tea catechin, epigallo-catechin 3-gallate (EGCG), and the major dietary protein and allerg
178 r green tea catechin, (-)-epigallocatechin-3-gallate (EGCG), but effects were observed only at microm
179 igate the interactions of epigallocatechin-3-gallate (EGCG), found in green tea, with Abeta polypepti
180 hibitor, green tea flavonol epigallocatechin-gallate (EGCG), from gestation to adulthood suppressed 3
181 id, caffeine, curcumin, (-)-epigallocatechin gallate (EGCG), gallic acid, propyl gallate, resveratrol
182 yrogallol-type catechins (epigallocatechin-3-gallate (EGCG), gallocatechin-3-gallate (GCG), and epica
183 nin, baicalein, curcumin, epigallocatechin 3-gallate (EGCG), genistein, quercetin, and resveratrol bo
184 tea extracts, catechin (-)-Epigallocatechin gallate (EGCg), has been reported to be biologically act
185 tuent of green tea, (-)-epigallocatechin-3-O-gallate (EGCG), has been shown to have cancer-preventive
186 molecules, FK506 and (-)-epigallocatechin-3-gallate (EGCG), known to inhibit alphaSYN fibril formati
187 d its major catechin, (-)-epigallocatechin-3-gallate (EGCG), on collagen homeostasis in keloid fibrob
189 yphenolic constituent (-)-epigallocatechin-3-gallate (EGCG), possesses remarkable cancer chemoprevent
190 their active ingredient, epigallocatechin-3-gallate (EGCG), protects cells from subsequent OGD/R-ind
194 It was hypothesized that epigallocatechin-gallate (EGCG), the main catechin present in green tea,
195 jection (20 mg/kg) of (-)-epigallocatechin-3-gallate (EGCG), the main polyphenolic constituent of gre
196 Here, we report that (-)-epigallocatechin-3-gallate (EGCG), the main polyphenolic constituent of gre
197 orted previously that (-)-epigallocatechin-3-gallate (EGCG), the major and most active component in g
200 we provide evidence that epigallocatechin-3-gallate (EGCG), the major polyphenol in green tea, is a
201 opical application of (-)-epigallocatechin-3-gallate (EGCG), the major polyphenol of green tea, preve
202 studies indicate that (-)-epigallocatechin-3-gallate (EGCG), the major polyphenol present in green te
203 t for the first time that epigallocatechin-3-gallate (EGCG), the major polyphenolic constituent of gr
208 ons with dopamine (DA) or epigallocatechin-3-gallate (EGCG), two inhibitors of AS aggregation, indica
210 en tea extract containing epigallocatequin-3-gallate (EGCG), which improves executive function in you
211 polyphenols, curcumin and epigallocatechin-3-gallate (EGCG), with that by the endogenous substrate he
212 We successfully synthesized epigallocatechin gallate (EGCG)-loaded nanoparticles (Enano), which were
216 n, epicatechin, and (-)-epigallocatechin-3-O-gallate (EGCG)] and bioflavonoids (quercetin, fisetin, a
217 c acid-GA, catechin-CAT and epigallocatechin gallate-EGCG) from processed and digested porridges with
218 5-MTHF) in combination with epigallocatechin-gallate-enriched extract (EGCGe) and epigallocatechin-en
219 mpferol, quercetin, epicatechin, epicatechin gallate, epigallocatechin gallate, genistein, daidzein,
220 erythrocyte hemolysis while (-)-epicatechin gallate, (-)-epigallocatechin gallate and (-)-epigalloca
221 degrees C: catechins [(-)-epigallocatechin-3-gallate, (-)-epigallocatechin, (-)-epicatechin-3-gallate
224 ate, (-)-epigallocatechin, (-)-epicatechin-3-gallate], flavones (kaempferol, kaempferol-3-glucoside,
226 locatechin-3-gallate (EGCG), gallocatechin-3-gallate (GCG), and epicatechin-3-gallate (ECG)) and not
227 echin, epicatechin gallate, epigallocatechin gallate, genistein, daidzein, caffeic acid, gallic acid)
228 ated with 20 micromol/L (-)-epigallocatechin gallate (green tea) was restored back to wild-type level
229 and polyphenols (vanillin, epigallocatechin gallate, green tea extract, and protocatechualdehyde) at
230 in the order punicalagin > epigallocatechin gallate > quercetagetin, with minimal interference using
232 The addition of Trolox, BHA, and propyl gallate had no significant effect on furan formation fro
237 enols, such as catechin and epigallocatechin gallate, have been used to augment the action of traditi
238 al agent (IC50=29.5 muM), followed by methyl gallate (IC50=38.0 muM, log P=-0.23) and alpha-tocophero
240 age capacity in vivo Proanthocyanidin trimer gallate in particular modified lipid desaturation in C.
241 as smaller than that of (-)-epigallocatechin gallate in Phase III clinical trials and about one order
243 in C2, epigallocatechin and epigallocatechin gallate) in a nutritional context to prevent Celiac Dise
244 dant capacity than their corresponding alkyl gallates, in emulsions prepared with lecithin or Tween-2
245 green tea polyphenol, (-)-epigellocathecin-3-gallate, is also inhibited by apigenin, suggesting that
247 enomena standpoint, gallic acid (GA), methyl gallate (MG), and their combination alone and together w
248 in the presence of gallic acid (GA), methyl gallate (MG), MG/GA combinations (75:25, 50:50, and 25:7
250 eptide, a tetraethylene glycol spacer, and a gallate moiety was designed, synthesized, and characteri
251 ds: rifampicin, curcumin, epigallocatechin-3-gallate, myricetin, and scyllo-inositol, in cells expres
253 para-nitrobenzoic acid (pNBA), and n-propyl gallate (nPG)--on bilayer properties using a gramicidin
254 ative, oligomerized (-)-epigallocatechin-3-O-gallate (OEGCG) as a carrier for oral lycopene delivery.
255 ors NADH and NADPH and is sensitive to octyl gallate (Ogal), a plastidial terminal oxidase inhibitor.
256 e green tea catechin, (-)-epigallocatechin-3-gallate or (-)-EGCG, has been shown to act as a proteaso
257 te treatment protocol, we administered ethyl gallate or norepinephrine after a sustained approximatel
260 the enzymatic transesterification of propyl gallate (PG) and tripalmitin under solvent-free conditio
262 ity of gallic acid (GA) and its ester propyl gallate (PG) in the presence of UV-A light against Esche
263 ized by the enzymatic glycerolysis of propyl gallate (PG) using a food-grade lipase (Lipozyme(R) 435)
264 The most active antioxidants were: propyl gallate (PG), (-)-epigallocatechin gallate (EGCG) and qu
266 the phenolic compounds catechin, epicatechin gallate, procyanidin B1, rutin, gallic acid, caffeic aci
268 1 and B2, catechin, epicatechin, epicatechin gallate, quercetin 3-beta-d-glucoside, delfinidin 3-gluc
270 ularly in the late treatment protocol, ethyl gallate resulted in a lower heart rate, a lower troponin
272 2 by the green tea compound epigallocatechin gallate results in an increase in [Ca(2+)](ER) due to in
273 catechin gallate (EGCG), gallic acid, propyl gallate, resveratrol, and alpha-tocopherol) were investi
274 Among these polyphenols, (-)-epicatechin-3-gallate showed the highest Stern-Volmer modified quenchi
275 llagic acid, limonin, oleanolic acid, propyl gallate, sinapic acid and ursolic acid demonstrated sign
277 3 pOPCs (dimer gallate, trimer and/or trimer gallate) suggested the absence of synergistic potential.
278 polyphenols, tannic acid (TA), theaflavin-3'-gallate (TF2B) and theaflavin-3,3'-digallate (TF3) exhib
279 st that phenolic antioxidants, such as ethyl gallate, that inhibit hydrogen peroxide signaling, may r
280 utrient screen, EGCG ((-)-epigallocatechin 3-gallate), the major phytochemical in green tea, emerged
282 flavin-3,3'-digallate (TFdiG), theaflavin-3'-gallate, theaflavin-3-gallate, and theaflavin inhibited
283 he antiaggregation compound epigallocatechin gallate, thereby maintaining the PrPSc as primarily nono
284 toxicity; moreover, despite epigallocatechin gallate treatment, pooled oM1000 remained oligomeric and
285 combination exposure of 2 or 3 pOPCs (dimer gallate, trimer and/or trimer gallate) suggested the abs
287 nt-based compounds (hippuric acid and propyl gallate) using cell- and membrane-based transport inhibi
288 hemodynamic and biochemical effects of ethyl gallate vs. those of the commonly used vasopressor, nore
289 stem, the natural product epigallocatechin 3-gallate was found to block Wnt signaling, independent of
290 ssays (MTT) we found that C8-propyl-catechin gallate was more active (IC50 = 31 microM) than catechin
292 gallocatechin gallate (EGCG) and epicatechin gallate were found to inhibit GDH with nanomolar ED(50)
295 efficacy of CPC separation, three glucoside gallates were subsequently isolated by HPLC chromatograp
296 epigallocatechin gallate and (-)-epicatechin gallate)] were most efficient in the inhibition of AAPH-
297 acid, vanillic acid, and epigallocatechin-3-gallate, were effective inhibitors of the activity of ca
298 ehavior of the antioxidant activity of alkyl gallates when increasing alkyl chain length was observed
299 nt of glioma cells with (-)-epigallocatechin gallate, which targets the ATP-binding domain of GRP78 a